Epinephrine decreases the dose of hyperbaric bupivacaine necessary for tourniquet pain blockade during spinal anesthesia for total knee replacement arthroplasty
Purpose We quantified the dose-sparing effect of epinephrine by comparing the median effective dose (ED 50 ) of intrathecal hyperbaric bupivacaine co-administered with epinephrine with the ED 50 of intrathecal hyperbaric bupivacaine alone. Methods Three groups were randomly generated from 162 patien...
Gespeichert in:
Veröffentlicht in: | Journal of anesthesia 2013-02, Vol.27 (1), p.72-79 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
We quantified the dose-sparing effect of epinephrine by comparing the median effective dose (ED
50
) of intrathecal hyperbaric bupivacaine co-administered with epinephrine with the ED
50
of intrathecal hyperbaric bupivacaine alone.
Methods
Three groups were randomly generated from 162 patients undergoing total knee replacement arthroplasty under combined spinal and epidural anesthesia: Group B (bupivacaine), Group BE1 (bupivacaine plus epinephrine 100 μg), and Group BE2 (bupivacaine plus epinephrine 200 μg). Each group was further divided by bupivacaine doses of 6, 7, 8, 9, 10, or 11 mg. The anesthesia was defined as successful if a bilateral T12 sensory block occurred within 15 min, and no intraoperative epidural supplement was required. The ED
50
and ED
95
for successful anesthesia and successful tourniquet pain blockade were determined separately by probit regression analysis.
Results
The ED
50
and ED
95
of intrathecal hyperbaric bupivacaine for successful anesthesia were not different among the groups: the ED
50
values were 7.1 mg [95 % confidence interval (95 % CI) 6.0–8.0 mg] in Group B, 6.2 mg (95 % CI 4.8–7.2 mg) in Group BE1, and 6.3 mg (95 % CI 4.9–7.2 mg) in Group BE2. However, the ED
50
and ED
95
values for tourniquet pain control were significantly smaller in Groups BE1 and BE2 than in Group B: the ED
50
values were 7.2 mg (95 % CI 6.3–7.9 mg), 5.5 mg (95 % CI 4.1–6.3 mg), and 5.3 mg (95 % CI 3.7–6.2 mg) in Groups B, BE1, and BE2, respectively. The incidence of tourniquet pain was significantly lower in Groups BE1 and BE2 than in Group B. The time to patients’ requests for supplemental analgesia was significantly longer in Groups BE1 and BE2 than in Group B.
Conclusions
Intrathecal epinephrine did not decrease the dose of intrathecal hyperbaric bupivacaine required for successful anesthesia. However, it reduced the dose required for tourniquet pain blockade. |
---|---|
ISSN: | 0913-8668 1438-8359 |
DOI: | 10.1007/s00540-012-1471-x |